RecombiVet Kutatási Fejlesztési és Diagnosztikai Kft.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RecombiVet Kutatási Fejlesztési és Diagnosztikai Kft.filedCriticalRecombiVet Kutatási Fejlesztési és Diagnosztikai Kft.
Priority to HU0002033ApriorityCriticalpatent/HUP0002033A2/en
Publication of HU0002033D0publicationCriticalpatent/HU0002033D0/en
Publication of HUP0002033A2publicationCriticalpatent/HUP0002033A2/en
208000037265diseases, disorders, signs and symptomsDiseases0.000title1
229960005486vaccineDrugs0.000title1
241000125945ProtoparvovirusSpecies0.000abstract2
241001465754MetazoaSpecies0.000abstract1
239000000427antigenSubstances0.000abstract1
102000036639antigensHuman genes0.000abstract1
108091007433antigensProteins0.000abstract1
208000024891symptomDiseases0.000abstract1
230000001018virulenceEffects0.000abstract1
Abstract
A preparation containing parvovirus with reduced virulence is administered, on its own or in conjunction with other antigens. It is expected that the inoculated animals will develop antibodies, preventing the development of symptoms which otherwise would be caused by the parvovirus.
HU0002033A2000-05-302000-05-30Vaccine against diseases caused by chicken parvovirus
HUP0002033A2
(en)
The glucan, adjuvant composition comprising the glucan as well as the use of the glucan for the preparation of a mucosally administrable adjuvant composition.